{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:15:21Z","timestamp":1748405721830,"version":"3.41.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"DOI":"10.7759\/cureus.84896","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:43:50Z","timestamp":1748357030000},"source":"Crossref","is-referenced-by-count":0,"title":["Tumor Lysis Syndrome After mFOLFOX6 Administration for Ascending Colon Cancer"],"prefix":"10.7759","author":[{"given":"Yuta","family":"Kano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhito","family":"Muranaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Honma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunosuke","family":"Takishin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kunieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2014.5389","article-title":"Tumor lysis syndrome in solid tumors: an up to date review of the literature","volume":"6","author":"Mirrakhimov AE","year":"2014","unstructured":"Mirrakhimov AE, Ali AM, Khan M, Barbaryan A. Tumor lysis syndrome in solid tumors: an up to date review of the literature. Rare Tumors. 2014, 6:5389. 10.4081\/rt.2014.5389","journal-title":"Rare Tumors"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3816\/SCT.2005.n.012","article-title":"Tumor lysis syndrome in solid tumors","volume":"2","author":"Mott FE","year":"2005","unstructured":"Mott FE, Esana A, Chakmakjian C, Herrington JD. Tumor lysis syndrome in solid tumors. Support Cancer Ther. 2005, 2:188-91. 10.3816\/SCT.2005.n.012","journal-title":"Support Cancer Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2016.10.040","article-title":"Tumor lysis syndrome in solid tumors: clinical characteristics and prognosis","volume":"148","author":"Caravaca-Font\u00e1n F","year":"2017","unstructured":"Caravaca-Font\u00e1n F, Mart\u00ednez-S\u00e1ez O, Pampa-Saico S, Olmedo ME, Gomis A, Garrido P. Tumor lysis syndrome in solid tumors: clinical characteristics and prognosis. Med Clin (Barc). 2017, 148:121-4. 10.1016\/j.medcli.2016.10.040","journal-title":"Med Clin (Barc)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.7.2.233","article-title":"Management of tumor lysis syndrome in adults","volume":"7","author":"Coiffier B","year":"2007","unstructured":"Coiffier B, Riouffol C. Management of tumor lysis syndrome in adults. Expert Rev Anticancer Ther. 2007, 7:233-9. 10.1586\/14737140.7.2.233","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13290","article-title":"Consensus conference on the management of tumor lysis syndrome","volume":"93","author":"Tosi P","year":"2008","unstructured":"Tosi P, Barosi G, Lazzaro C, et al.. Consensus conference on the management of tumor lysis syndrome. Haematologica. 2008, 93:1877-85. 10.3324\/haematol.13290","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo MS","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004, 127:3-11. 10.1111\/j.1365-2141.2004.05094.x","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8355","article-title":"Tumor lysis syndrome in solid tumors: a comprehensive literature review, new insights, and novel strategies to improve outcomes","volume":"12","author":"Findakly D","year":"2020","unstructured":"Findakly D, Luther RD 3rd, Wang J. Tumor lysis syndrome in solid tumors: a comprehensive literature review, new insights, and novel strategies to improve outcomes. Cureus. 2020, 12:e8355. 10.7759\/cureus.8355","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier B","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008, 26:2767-78. 10.1200\/JCO.2007.15.0177","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2014.46.2.204","article-title":"Tumor lysis syndrome in a patient with metastatic colon cancer after treatment with 5-fluorouracil\/leucovorin and oxaliplatin: case report and literature review","volume":"46","author":"Kim HD","year":"2014","unstructured":"Kim HD, Ha KS, Woo IS, Jung YH, Han CW, Kim TJ. Tumor lysis syndrome in a patient with metastatic colon cancer after treatment with 5-fluorouracil\/leucovorin and oxaliplatin: case report and literature review. Cancer Res Treat. 2014, 46:204-7. 10.4143\/crt.2014.46.2.204","journal-title":"Cancer Res Treat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5348\/ijcri-201678-CR-10666","article-title":"Tumor lysis syndrome in metastatic colon cancer after single FOLFOX cycle","volume":"7","author":"Agrawal A","year":"2016","unstructured":"Agrawal A, Jain D, Morginstin M. Tumor lysis syndrome in metastatic colon cancer after single FOLFOX cycle. Int J Case Rep Imag. 2016, 7:445. 10.5348\/ijcri-201678-CR-10666","journal-title":"Int J Case Rep Imag"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223474","article-title":"Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer","volume":"2018","author":"Gouveia HS","year":"2018","unstructured":"Gouveia HS, Lopes SO, Faria AL. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-223474","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8257","article-title":"A retrospective review of tumor lysis syndrome associated with colorectal cancer","volume":"12","author":"Ansari Z","year":"2020","unstructured":"Ansari Z, Findakly D, Wang J. A retrospective review of tumor lysis syndrome associated with colorectal cancer. Cureus. 2020, 12:e8257. 10.7759\/cureus.8257","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S103864","article-title":"Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase","volume":"10","author":"Alakel N","year":"2017","unstructured":"Alakel N, Middeke JM, Schetelig J, Bornh\u00e4user M. Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. Onco Targets Ther. 2017, 10:597-605. 10.2147\/OTT.S103864","journal-title":"Onco Targets Ther"},{"key":"ref14","article-title":"Reduced tumor lysis syndrome with low dose chemotherapy for hyperleukocytic acute leukemia prior to induction therapy","volume":"12","author":"Liang R","year":"2011","unstructured":"Liang R, Bai QX, Zhang YQ, et al.. Reduced tumor lysis syndrome with low dose chemotherapy for hyperleukocytic acute leukemia prior to induction therapy. Asian Pac J Cancer Prev. 2011, 12:1807-11.","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/364328-tumor-lysis-syndrome-after-mfolfox6-administration-for-ascending-colon-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:43:52Z","timestamp":1748357032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/364328-tumor-lysis-syndrome-after-mfolfox6-administration-for-ascending-colon-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.84896","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}